28,869 Shares in The Clorox Company (NYSE:CLX) Acquired by Algert Global LLC

Algert Global LLC acquired a new stake in shares of The Clorox Company (NYSE:CLX) in the fourth quarter, Holdings Channel reports. The firm acquired 28,869 shares of the company’s stock, valued at approximately $4,689,000.

Several other hedge funds have also added to or reduced their stakes in CLX. Integral Investment Advisors Inc. raised its position in shares of Clorox by 4.1% in the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after purchasing an additional 67 shares during the last quarter. HCR Wealth Advisors raised its holdings in Clorox by 1.0% in the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after buying an additional 68 shares during the last quarter. Sound View Wealth Advisors Group LLC lifted its stake in shares of Clorox by 6.1% in the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock worth $218,000 after buying an additional 77 shares in the last quarter. Wedbush Securities Inc. grew its holdings in shares of Clorox by 1.2% during the fourth quarter. Wedbush Securities Inc. now owns 7,624 shares of the company’s stock valued at $1,238,000 after buying an additional 94 shares during the last quarter. Finally, Brooklyn Investment Group increased its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Stock Down 0.5 %

Shares of CLX stock opened at $138.35 on Tuesday. The company has a 50 day simple moving average of $143.85 and a two-hundred day simple moving average of $154.69. The stock has a market cap of $17.04 billion, a P/E ratio of 37.80, a P/E/G ratio of 2.62 and a beta of 0.60. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX) last announced its earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. Clorox’s revenue for the quarter was down 8.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.71 earnings per share. On average, research analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.53%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio is 133.33%.

Analyst Ratings Changes

Several analysts have commented on the company. JPMorgan Chase & Co. cut their target price on Clorox from $173.00 to $151.00 and set a “neutral” rating on the stock in a research note on Friday, April 11th. Barclays dropped their price objective on Clorox from $139.00 to $134.00 and set an “underweight” rating on the stock in a research report on Friday, April 11th. Wells Fargo & Company decreased their target price on Clorox from $155.00 to $145.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 16th. Citigroup dropped their price target on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a report on Monday, April 14th. Finally, UBS Group decreased their price objective on shares of Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a report on Thursday, April 17th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $153.83.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.